Here are five recent oncology-related studies published by Becker's since July 12, starting with the most recent:
The Latest
Houston-based University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, a technology company, entered an exclusive license and joint development agreement Aug. 10.
OU Health Stephenson Cancer center has joined the Caris Precision Oncology alliance.
An Austrian study led by MedUni Vienna showed a partial or complete regression of brain metastasis in breast cancer patients after treatment with trastuzumab deruxtecan (T-Dxd).
Oncologists’ average income rose about 2 percent to $411,000 in 2022, according to Medscape's "Oncologist Wealth & Debt Report," published Aug. 5.
President Joe Biden will appoint Monica Bertagnolli, MD, as the new director of the National Cancer Institute.
Chicago-based Northwestern Medicine expanded its cancer care to Chicago's south suburbs with the opening of the Northwestern Cancer Center Orland Park Aug. 9.
New York City-based Mount Sinai has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with KRAS gene mutations.
Mayo Clinic Jacksonville (Fla.) began site work on its $233 million integrated oncology building, The Jacksonville Daily Record reported Aug. 8.
Morganstown, W. Va-based WVU Cancer Institute became the first facility in the state to administer Pluvicto, a radiation pharmaceutical administered through injection or infusion, for a type of metastatic prostate cancer, local news website My Buckhannon reported Aug. 7.